Much of the licensed cannabis industry is quietly counting the volume it expects to inherit from the federal hemp ban coming this November. \*\* Now December. What they may not realize is that the ban could eliminate the full-spectrum therapeutic hemp formulations that helped change America's view of cannabis and are used daily by an estimated 45 million Americans. The provision was written by two members of Congress, without a conference or regular order, and inserted into a massive spending bill during the longest government shutdown in American history. What should have been handled with a scalpel was done with a sledgehammer. This week we sit down with Paige Figi to discuss • Silence is a position • The scalpel Congress skipped • Oval Office, then banned
Much of the licensed cannabis industry is quietly counting the volume it expects to inherit from the federal hemp ban coming this November. ** Now December.
What they may not realize is that the ban could eliminate the full-spectrum therapeutic hemp formulations that helped change America's view of cannabis and are used daily by an estimated 45 million Americans.
The provision was written by two members of Congress, without a conference or regular order, and inserted into a massive spending bill during the longest government shutdown in American history.
What should have been handled with a scalpel was done with a sledgehammer.
This week we sit down with Paige Figi to discuss
• Silence is a position
• The scalpel Congress skipped
• Oval Office, then banned
Chapters
00:00 Introduction to the legislative landscape of cannabis
00:21 The impact of Charlotte's story on cannabis perception
00:48 Distinguishing hemp from marijuana in legislation
02:11 The challenges of passing therapeutic hemp laws
02:52 Congress's need for simple, effective regulation
03:48 The slow progress of therapeutic hemp legalization
04:53 The importance of clear plant distinctions
05:56 The November 12 hemp ban and its implications
07:02 The dangers of Franken hemp and synthetic cannabinoids
08:00 The public health emergency posed by recent bans
08:49 The role of science and data in regulation
10:13 The importance of industry and public unity
10:58 How regulations can support medical and adult use
12:06 The impact of federal bans on patients and consumers
13:00 The need for a balanced, science-based approach
14:00 The political landscape and legislative hurdles
14:53 The power of public advocacy and individual action
16:07 The future of cannabis regulation and industry alignment
17:06 How to effectively communicate with policymakers
18:03 The importance of clear, science-backed legislation
19:00 The role of the FDA and federal agencies
20:01 The potential for bipartisan support and progress
21:08 The significance of the November 12 deadline
22:06 The ongoing fight for access and regulation
23:04 The moral and ethical considerations in cannabis policy
23:49 How consumers can influence policy change
24:47 The importance of unity within the industry
25:46 The potential for a balanced, effective regulatory framework
27:06 The role of science and data in shaping policy
28:03 The need for responsible, clear regulations
29:02 The future outlook for therapeutic hemp and CBD
30:02 Final thoughts and call to action
Guest Links
https://www.coalitionforaccess.org/
https://www.instagram.com/paigefigi/
https://realmofcaring.org/about/paige-figi/
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime